UBS Group’s NEPHROGENEX INC COM NRX Stock Holding History

UBS Group’s Portfolio NRX Stock Details NRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,573	Closed	-$4K	–	8307
2016 Q1	$4K	Buy	+8,573	New	+$7.13K	﹤0.01%	7152
2015 Q3	–	Sell	-591	Closed	-$4K	–	8925
2015 Q2	$4K	Sell	591 -1,725	-74%	-$13.1K	﹤0.01%	8029
2015 Q1	$18K	Sell	2,316 -383	-14%	-$3.01K	﹤0.01%	7119
2014 Q4	$36K	Buy	+2,699	New	+$12.5K	﹤0.01%	6916

UBS Group's NRX Position: Q2 2016 in Review

UBS Group sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 8,573 shares — an estimated $4K sold.

UBS Group first reported a position in NRX in Q4 2014 and held it in 4 quarters. The position peaked at $36K in Q4 2014. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

UBS Group reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
UBS Group sold 8,573 NEPHROGENEX INC COM shares in Q2 2016, an estimated $4K.
UBS Group first reported a position in NEPHROGENEX INC COM in Q4 2014 and held it in 4 quarters.
UBS Group's NEPHROGENEX INC COM position peaked at $36K in Q4 2014.
1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.